Hacioglu MB - Search Results

1

Major and minor salivary gland cancers: A multicenter retrospective study.

Hacioglu MB, Erdogan B, Bardakcı M, Algın E, Gulbagcı B, Hacibekiroglu I, Hamdard J, Olmez OF, Akkus H, Oksuzoglu B, Goksu SS, Dae SA, Sumbul AT, Ugraklı M, Karaagac M, Sahin E, Cabuk D, Ozer O, Yavuzsen T, Arıkan R, Köstek O, Atcı MM, Sakin A, Deligonul A, Bayır D, Dincer M, Unsal O, Yazıcı O, Zeynelgil E, Gulmez A, Harputluoglu H, Erol C, Sendur MAN, Aytekin A, Akagunduz B, Oner I, Er O, Oztosun B, Gumus M, Selçukbiricik F, Aykan MB, Karadurmus N, Degerli E, Demirci NS, Turkmen E, Şakalar T, Secmeler S, Tanrıverdi O, Alkan A, Kemal Y, Cil I, Unal C, Iriagaç Y, Alan O, Balli S, Urun Y, Ozcan E, Turhal NS, Cicin I. Hacioglu MB, et al. Head Neck. 2023 Jul;45(7):1643-1653. doi: 10.1002/hed.27376. Epub 2023 Apr 21. Head Neck. 2023. PMID: 37084179

2

A rare coexistence--Chronic lymphocytic leukemia and Kaposi sarcoma: Case report and review of the literature.

Hacioglu MB, Sahin S, Karatas F, Aytekin A. Hacioglu MB, et al. J Cancer Res Ther. 2015 Oct-Dec;11(4):954-6. doi: 10.4103/0973-1482.165863. J Cancer Res Ther. 2015. PMID: 26881554 Free article.

3

Clinical features of the patient with multiple primary tumors: Single center experience.

Gokyer A, Kostek O, Hacioglu MB, Erdogan B, Kodaz H, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. Gokyer A, et al. Among authors: hacioglu mb. North Clin Istanb. 2017 May 10;4(1):43-51. doi: 10.14744/nci.2017.67044. eCollection 2017. North Clin Istanb. 2017. PMID: 28752142 Free PMC article.

4

Renal cell carcinoma presenting with heart metastasis without inferior vena caval and right atrial involvement.

Sahin S, Karatas F, Hacioglu MB, Aytekin A, Cilbir E, Conkbayir I. Sahin S, et al. Among authors: hacioglu mb. J Cancer Res Ther. 2018 Jan-Mar;14(2):457-458. doi: 10.4103/0973-1482.193111. J Cancer Res Ther. 2018. PMID: 29516940 Free article.

5

Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma.

Karatas F, Sahin S, Aytekin A, Hacioglu MB, Imamoglu GI, Altinbas M. Karatas F, et al. Among authors: hacioglu mb. J Cancer Res Ther. 2018 Jul-Sep;14(5):1149-1151. doi: 10.4103/0973-1482.188293. J Cancer Res Ther. 2018. PMID: 30197367 Free article.

6

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Köstek O, Hacıoğlu MB, Sakin A, Demir T, Sarı M, Ozkul O, Araz M, Doğan AF, Demircan NC, Uzunoğlu S, Çiçin İ, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Cancer Chemother Pharmacol. 2019 Jan;83(1):115-122. doi: 10.1007/s00280-018-3713-6. Epub 2018 Oct 29. Cancer Chemother Pharmacol. 2019. PMID: 30374523

7

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer.

Köstek O, Yılmaz E, Hacıoğlu MB, Demircan NC, Gökyer A, Uzunoğlu S, Tunçbilek N, Çiçin İ, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Cancer Chemother Pharmacol. 2019 Apr;83(4):735-742. doi: 10.1007/s00280-019-03779-5. Epub 2019 Jan 24. Cancer Chemother Pharmacol. 2019. PMID: 30680522

8

Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.

Gökyer A, Küçükarda A, Köstek O, Hacıoğlu MB, Sunal BS, Demircan NC, Uzunoğlu S, Solak S, İşsever K, Çiçin I, Erdoğan B. Gökyer A, et al. Among authors: hacioglu mb. Clin Transl Oncol. 2019 Nov;21(11):1518-1523. doi: 10.1007/s12094-019-02080-4. Epub 2019 Mar 13. Clin Transl Oncol. 2019. PMID: 30868388

9

Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer.

Köstek O, Demircan NC, Gökyer A, Küçükarda A, Sunal BS, Hacıoğlu MB, Eslame H, Solak S, Yılmaz E, Uzunoğlu S, Tunçbilek N, Çiçin I, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Clin Transl Oncol. 2019 Nov;21(11):1510-1517. doi: 10.1007/s12094-019-02079-x. Epub 2019 Mar 28. Clin Transl Oncol. 2019. PMID: 30924091

10

Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?

Köstek O, Bozkaya Y, Hacıoğlu MB, Yıldırım Özdemir N, Yılmaz E, Demircan NC, Erdoğan B, Uzunoğlu S, Çiçin İ, Zengin N. Köstek O, et al. Among authors: hacioglu mb. Arch Iran Med. 2019 May 1;22(5):236-241. Arch Iran Med. 2019. PMID: 31256595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters